logo
logo

Sona Nanotech Inc signs clinical trial agreement for targeted hyperthermia therapy in Chile.

Sona Nanotech Inc signs clinical trial agreement for targeted hyperthermia therapy in Chile.

06/21/25, 7:59 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svgdartmouth
Industry
biotechnology
health care
Type
agreement
Sona Nanotech has signed a clinical trial agreement for a study in Chile focusing on late-stage melanoma patients. The trial will apply their targeted hyperthermia therapy and monitor its safety and tolerability over a 28-day period.

Company Info

Company
Sona Nanotech
Location
dartmouth, nova scotia, canada
Additional Info
Sona Nanotech Inc. is a nanotechnology life sciences company that is developing Targeted Hyperthermia Therapy (THT) for cancer treatment, using its unique biocompatible gold nanorod platform technology.

Related People

Upgrade to Unlock

Unlock Verified Contacts + AI Outreach

Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.

Ch

Ch • Executive

Email hidden • Upgrade to unlock

Upgrade & Unlock

Trusted by teams at Google, Oracle, HubSpot & more